Related Experiment Video

Updated: Sep 3, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.0K

Updates on Coronavirus Disease 2019 in Children in Japan

Yuta Aizawa1, Sayaka Takanashi2, Chikara Ogimi3

  • 1From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

The Pediatric Infectious Disease Journal
|July 27, 2022
PubMed

Insights

This review summarizes COVID-19 in Japanese children, noting favorable outcomes despite variant changes. Improving vaccination rates, especially for younger children, requires further action.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has impacted children globally, with varying clinical outcomes.
  • Japan experienced six waves of COVID-19 by March 2022, with evolving clinical features in pediatric cases.
  • Understanding pediatric COVID-19 trends in Japan is crucial for public health strategies.

Purpose of the Study:

  • To review and summarize published data on coronavirus disease 2019 (COVID-19) in children in Japan.
  • To analyze the changes in clinical features of pediatric COVID-19 based on predominant variants.
  • To assess the clinical outcomes and vaccination status of children in Japan during the pandemic.

Main Methods:

  • Systematic review of published data on pediatric COVID-19 in Japan.
  • Analysis of clinical features in relation to COVID-19 variants.
  • Comparison of outcomes with European countries and the United States.
  • Evaluation of COVID-19 vaccine uptake in different pediatric age groups.

Main Results:

  • Clinical features of pediatric COVID-19 in Japan have evolved with different variants.
  • Favorable clinical outcomes in Japanese children compared to some Western countries, potentially due to lower rates of multisystem inflammatory syndrome in children and obesity.
  • COVID-19 vaccination is available for children, but uptake in the 5-11 age group is low.
  • The government's passive approach has contributed to lower vaccination rates in younger children.

Conclusions:

  • Pediatric COVID-19 outcomes in Japan have been relatively favorable.
  • Targeted strategies are needed to increase COVID-19 vaccination rates in children, particularly those aged 5-11.
  • Continued monitoring and research are essential for managing pediatric COVID-19.

More Related Videos

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children06:22

Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children

Published on: February 10, 2023

1.1K
Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

21.5K

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
176
Vaccinations01:51

Vaccinations

Overview
45.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
169
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
765
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K